We are live on ! Find out more
GMO

General Moly, Inc.
GMO

Delisted

GMO was delisted on the 30th of September, 2020.

59 hedge funds and large institutions have $19.1M invested in General Moly, Inc. in 2014 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 23 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

4% more funds holding

Funds holding: 5759 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

31% less capital invested

Capital invested by funds: $27.7M → $19.1M (-$8.59M)

61% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 23

Holders
59
Holders Change
+2
Holders Change %
+3.51%
% of All Funds
1.7%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
9
Reduced
23
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$63K -$23.7K -19,500 -24%
ProShare Advisors
27
ProShare Advisors
Maryland
$58K +$70.5K +58,101 New
VKH
28
Virtu KCG Holdings
New York
$54K -$62.8K -51,754 -49%
NFA
29
Nationwide Fund Advisors
Ohio
$45K
Bank of America
30
Bank of America
North Carolina
$44K -$537 -442 -1%
CS
31
Credit Suisse
Switzerland
$44K +$7.75K +6,380 +17%
AI
32
ArchPoint Investors
Florida
$43K
BA
33
BlackRock Advisors
Delaware
$41K
AIG
34
American International Group
New York
$38.8K +$1.14K +938 +2%
GC
35
Guggenheim Capital
Illinois
$32K +$39K +32,144 New
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$30K -$117K -96,538 -76%
Deutsche Bank
37
Deutsche Bank
Germany
$25K +$17.6K +14,468 +123%
TRCT
38
Tower Research Capital (TRC)
New York
$24K +$29.2K +24,016 +17,154%
CL
39
CSS LLC
Illinois
$21K
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$18K -$24.9K -20,503 -53%
Fidelity Investments
41
Fidelity Investments
Massachusetts
$16K +$19.1K +15,700 New
ARTA
42
A.R.T. Advisors
New York
$13K -$3.87K -3,189 -19%
GA
43
Geneva Advisors
Illinois
$13K
PA
44
Profund Advisors
Maryland
$11K +$13.1K +10,800 New
OC
45
Oppenheimer & Co
New York
$10K
Wells Fargo
46
Wells Fargo
California
$10K +$6.19K +5,100 +102%
Citigroup
47
Citigroup
New York
$9K -$16.6K -13,703 -61%
Morgan Stanley
48
Morgan Stanley
New York
$9K -$4.94K -4,066 -31%
U
49
UBS
Switzerland
$6K -$26.5K -21,838 -78%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$4K -$7.35K -6,055 -60%

GMO Hedge Fund Activity: Q1 2014 in Review

59 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in General Moly, Inc. (GMO) for Q1 2014, worth a combined $19.1M — down 31% from $27.7M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new GMO positions and 7 closed out — a net gain of 2 holders — while 9 added to existing stakes and 23 trimmed.

The largest buyer was BTG Pactual Global Asset Management, opening a new position worth an estimated $300K. The largest seller was Cannell Capital, cutting an estimated $1.54M.

  • 59 institutional investors held General Moly, Inc. (GMO) as of Q1 2014, up from 57 in Q4 2013.
  • Funds reported $19.1M of General Moly, Inc. stock for Q1 2014, down 31% quarter-over-quarter.
  • 9 funds opened new General Moly, Inc. positions in Q1 2014 and 7 closed out, a net change of +2 holders.
  • The largest General Moly, Inc. buyer in Q1 2014 was BTG Pactual Global Asset Management, an estimated $300K added.
  • The largest General Moly, Inc. seller in Q1 2014 was Cannell Capital, an estimated $1.54M sold.

Based on aggregated 13F filings for Q1 2014.